The University of Chicago Header Logo

Connection

Robert Rosenfield to Dexamethasone

This is a "connection" page, showing publications Robert Rosenfield has written about Dexamethasone.
Connection Strength

0.878
  1. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Hum Reprod. 2011 Nov; 26(11):3138-46.
    View in: PubMed
    Score: 0.360
  2. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J Clin Endocrinol Metab. 2003 Dec; 88(12):6115; author reply 6115-6.
    View in: PubMed
    Score: 0.210
  3. Dexamethasone preparation does not alter corticoid and androgen responses to adrenocorticotropin. J Clin Endocrinol Metab. 1985 Mar; 60(3):585-9.
    View in: PubMed
    Score: 0.057
  4. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5:1285-9.
    View in: PubMed
    Score: 0.040
  5. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor--a clinical research center study. J Clin Endocrinol Metab. 1996 Oct; 81(10):3802-6.
    View in: PubMed
    Score: 0.032
  6. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
    View in: PubMed
    Score: 0.028
  7. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann N Y Acad Sci. 1993 May 28; 687:162-81.
    View in: PubMed
    Score: 0.025
  8. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr. 1983 Mar; 102(3):461-4.
    View in: PubMed
    Score: 0.012
  9. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod. 2002 Jan; 17(1):88-91.
    View in: PubMed
    Score: 0.012
  10. Pubertal presentation of congenital delta 5-3 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1980 Aug; 51(2):345-53.
    View in: PubMed
    Score: 0.010
  11. Amenorrhea related to progestin excess in congenital adrenal hyperplasia. Obstet Gynecol. 1980 Aug; 56(2):208-15.
    View in: PubMed
    Score: 0.010
  12. Testosterone binding and free plasma androgen concentrations under physiological conditons: chararacterization by flow dialysis technique. J Clin Endocrinol Metab. 1979 Nov; 49(5):730-6.
    View in: PubMed
    Score: 0.010
  13. The effects of dexamethasone on plasma free androgens during the normal menstrual cycle. Am J Obstet Gynecol. 1976 Dec 15; 126(8):982-6.
    View in: PubMed
    Score: 0.008
  14. Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia. J Clin Invest. 1975 Apr; 55(4):681-90.
    View in: PubMed
    Score: 0.007
  15. Sertoli-Leydig cell tumor of the ovary, with an associated mucinous cystadenoma. An ultrastructural and endocrine study. Lab Invest. 1974 Dec; 31(6):648-57.
    View in: PubMed
    Score: 0.007
  16. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994 Nov; 79(5):1328-33.
    View in: PubMed
    Score: 0.007
  17. The response to human chorionic gonadotropin (HCG) administration in boys with and without delta5-3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1974 Aug; 39(2):370-4.
    View in: PubMed
    Score: 0.007
  18. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
    View in: PubMed
    Score: 0.006
  19. Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women. J Clin Endocrinol Metab. 1972 Jan; 34(1):92-8.
    View in: PubMed
    Score: 0.006
  20. Plasma 17-ketosteroids and 17-beta hydroxysteroids in girls with premature development of sexual hair. J Pediatr. 1971 Aug; 79(2):260-6.
    View in: PubMed
    Score: 0.006
  21. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
    View in: PubMed
    Score: 0.005
  22. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. J Clin Endocrinol Metab. 1982 Aug; 55(2):251-7.
    View in: PubMed
    Score: 0.003
  23. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981 Aug 01; 140(7):815-30.
    View in: PubMed
    Score: 0.003
  24. Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab. 1981 Jun; 52(6):1129-36.
    View in: PubMed
    Score: 0.003
  25. Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries. Am J Obstet Gynecol. 1979 Jun 15; 134(4):445-52.
    View in: PubMed
    Score: 0.002
  26. The measurement of urinary testosterone glucuronide by competitive protein binding and validation by a double isotope derivative assay. Steroids. 1969 Feb; 13(2):227-45.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.